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SUBJECTS: 




In an effort to probe the structure of the reaction intermediate of metallo-β-lactamase L1 when reacted with 
nitrocefin and other β-lactams, time-dependent absorption and rapid-freeze-quench (RFQ) EPR spectra were 
obtained using the Co(II)-substituted form of the enzyme. When using nitrocefin as the substrate, time-
dependent absorption spectra demonstrate that Co(II)-substituted L1 utilizes a reaction mechanism, similar to 
that of the native Zn(II) enzyme, in which a short-lived intermediate forms. RFQ-EPR spectra of this intermediate 
demonstrate that the binding of substrate results in a change in the electronic properties of one or both of the 
Co(II)'s in the enzyme that is consistent with a change in the coordination sphere of this metal ion. This 
observation provides evidence that the reaction intermediate is a metal-bound species. RFQ-EPR studies also 
demonstrate that other β-lactams, such as cephalothin, meropenem, and penicillin G, proceed through an 
electronically similar complex and that the role of metal is similar in all cases. EPR spectroscopy has also 
identified distinct product-bound species of L1, indicating that reversible product binding must be considered in 
all future kinetic mechanisms. Consideration of the time-dependent optical and EPR studies in light of available 
crystallographic information indicates the intimate involvement of the metal ion in the Zn2-binding site of L1 in 
the hydrolytic reaction. 
 
The ability of bacteria to acquire resistance to antibiotics is a serious problem that continues to challenge 
modern society (1). Excessive use, and often misuse, of antibiotics in the clinic and for agricultural purposes has 
resulted in tremendous selective pressure for antibiotic-resistant bacteria (2). These bacteria utilize a variety of 
methods to become resistant, including modification of cell wall components to prevent antibiotic binding, 
expression of efflux pumps that transport the antibiotic out of the cell, and the production of enzymes that 
modify and render antibiotics ineffective (1, 2). 
The most common, least expensive, and effective antibiotics currently used are the β-lactams, such as 
carbapenems, cephalosporins, and penicillins (3, 4). These antibiotics are mechanism-based inhibitors of 
transpeptidase, a bacterial enzyme required for the production of a strong, viable cell wall (5, 6). In response to 
their widespread use, an increasing number of bacterial strains have acquired the ability to produce β-
lactamases, enzymes that hydrolyze and render β-lactam antibiotics ineffective. There are over 300 distinct β-
lactamases known, and Bush has classified these into four distinct groups on the basis of their molecular 
properties (5, 6). One of the more troubling of these is group 3, the metallo-β-lactamases, which are Zn(II)-
dependent enzymes that hydrolyze nearly all known β-lactams and for which there are no clinically useful 
inhibitors (7−14). To date, there are no reports of a metallo-β-lactamase being isolated from a major pathogen 
(15, 16); however, these enzymes are produced by a variety of minor clinical pathogens such as Bacteroides 
fragilis, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia, and the continued extensive use of β-
lactam-containing antibiotics will inevitably result in the production of a metallo-β-lactamase by a major 
pathogen (2). 
There is significant diversity within the metallo-β-lactamases, and Bush, on the basis of their amino acid 
sequence identities and substrate affinities, has further divided them into three subgroups (17). A similar 
grouping scheme based on structural properties has also been offered (18). The diversity of these subgroups is 
best exemplified by their vastly differing efficacies toward nonclinical inhibitors; these differences lead to the 
prediction that finding a single inhibitor for all metallo-β-lactamases may not be possible (14, 19−27. To address 
this problem, we are currently characterizing a representative enzyme from each of the metallo-β-lactamase 
subgroups with the goal of identifying common structural and mechanistic similarities that can be targeted for 
the generation of clinically useful inhibitors. This work describes our efforts on metallo-β-lactamase L1 from S. 
maltophilia (L1).1 
S. maltophilia is an important pathogen in nosocomial infections of immunocompromised patients suffering 
from cancer, cystic fibrosis, drug addition, and AIDS and in patients with organ transplants and on dialysis 
(28−30). This organism is inherently resistant to most antibiotics due to its low outer membrane permeability 
(31) and is particularly resistant to β-lactams due to the production of a chromosomally expressed group 2e β-
lactamase (L2) and a group 3c β-lactamase (L1) (32, 33). L1 has been cloned, overexpressed, and partially 
characterized by kinetic and crystallographic studies (34, 35). The enzyme exists as a homotetramer of ca. 118 
kDa in solution and in the crystalline state, tightly binding two Zn(II) ions per subunit. The Zn1 site has three 
histidine residues and one bridging hydroxide as ligands, and the Zn2 site has two histidines, one aspartic acid, 
one terminally bound water, and the bridging hydroxide as ligands (Figure 1). 
 
Figure 1 Proposed metal binding site of metallo-β-lactamase L1 when bound to the reaction intermediate. Figure 
rendered with CS ChemDraw Ultra version 5.0. 
 
Efforts to solve the crystal structure of one of the metallo-β-lactamases with a bound substrate molecule have 
failed, most likely due to the high activity of the enzymes, even in the crystalline state, toward all β-lactam-
containing antibiotics (35, 36). Therefore, computational studies have been used extensively to provide insight 
into substrate binding, the role of the Zn(II) ions in catalysis, the protonation state of the active site, protein 
dynamics, and inhibitor binding (35, 37−42. 
Previous studies on metallo-β-lactamase CcrA from B. fragilis (43) and L1 (44, 45) have led to proposals for a 
mechanism of catalytic hydrolysis in which intermediates in catalysis may be stabilized by the active site metal 
ions (43, 46). In the present work, we demonstrate that a chromophoric, substrate-derived species is formed 
within a kinetically relevant time. We also show that the electronic structures of the catalytic metal ions are 
perturbed concomitantly with formation of this intermediate species. For the first time, direct evidence for the 
involvement of the metal ions in non-rate-limiting formation of a catalytic cycle intermediate is presented. 
Further insight into the catalytic mechanism is gleaned from studies with three classes of substrate. 
Experimental Procedures 
Escherichia coli strains DH5α and BL21(DE3) were obtained from Gibco-BRL and Novagen, respectively. The 
plasmid pET26b was purchased from Novagen. Luria−Bertani (LB) media in powder form were purchased from 
Gibco-BRL. Isopropyl β-thiogalactoside (IPTG), biotech grade, was procured from Anatrace. Protein solutions 
were concentrated with an Amicon ultrafiltration cell equipped with YM-10 DIAFLO membranes from Amicon, 
Inc. Dialysis tubing was prepared using Spectra/Por regenerated cellulose molecular porous membranes with a 
molecular weight cutoff of 6000−8000 (47). Q-Sepharose Fast Flow was purchased from Amersham Pharmacia 
Biotech. 1,10-Phenanthroline was purchased from Sigma. Nitrocefin was purchased from Becton Dickinson, and 
solutions of nitrocefin were filtered through a Fisherbrand 0.45 μm syringe filter (34). Cephalothin and penicillin 
G were purchased from Sigma and Fisher, respectively. Meropenem was generously supplied by Zeneca 
Pharmaceuticals. Ring-opened analogues of the antibiotics were prepared by adding catalytic amounts of L1 to 
concentrated solutions of the antibiotic and allowing the reactions to proceed to completion. All buffers and 
media were prepared using Barnstead NANOpure ultrapure water. 
Large-scale (4 L) preparations of the L1 were performed as described previously (34). Protein purity was 
ascertained by SDS−PAGE. Purified protein was dialyzed versus 6 × 1 L of 50 mM HEPES, pH 7.0, with 5 mM 1,10-
phenanthroline, over 36 h at 4 °C, followed by dialysis versus 6 × 1 L of metal-free 50 mM HEPES, pH 7.0, over 36 
h at 4 °C, to yield apo-L1. Two equivalents of Co(II) was added per apo-L1 monomer using published methods 
(48). Co(II) incorporation was confirmed by comparing the EPR spectra of Co(II)-L1 and HEPES buffer containing 1 
mM Co(II). The spectra were quite distinguishable, and there was no evidence for Co(II)-HEPES in the Co(II)-L1 
samples. 
Time-dependent spectrophotometric studies of nitrocefin hydrolysis by Co(II)-substituted L1 were performed on 
an Applied Photophysics SX.18MV stopped-flow spectrophotometer, as previously described (49, 50). 
Samples for EPR studies were generated using a modified Update Instruments (Madison, WI) rapid-freeze-
quench (RFQ) system. All enzyme and substrate starting sample concentrations were 1 mM (except penicillin G 
which was 4 mM), prepared in metal-free (Chelex 100, Bio-Rad) 50 mM HEPES, pH 7.0. A model 715 Update 
Instruments ram controller was used to drive a PMI-Kollmorgen stepping motor (model 010-00205-010) 
connected to a ram that in turn drove the Update Instrument syringes. The syringes, mixer, and tubing were all 
contained in a watertight bath that was maintained at 2 °C using iced water. Immediately prior to sample 
collection, the nozzle (and, for the shortest reaction times, the attached mixer) was removed from the bath and 
held 5 mm above the surface of 2-methylbutane (Fisher) contained in a collecting funnel and maintained at −130 
°C by a surrounding bath (Update Instruments) of liquid nitrogen cooled 2-methylbutane. Samples were packed 
into EPR tubes at −130 °C, excess 2-methylbutane was decanted, and samples were stored in liquid nitrogen 
prior to EPR examination, typically within 1 h of sample generation. The RFQ system was calibrated by 
comparing the development of a low-spin Fe(III) EPR signal and the disappearance of a high-spin Fe(III) EPR 
signal with the associated optical changes at 636 nm using stopped-flow spectrophotometry, upon mixing 
myoglobin with an excess of sodium azide. The shortest, total effective reaction time that could be achieved 
with the RFQ system was 10 ms. 
EPR spectra were recorded using a Bruker EleXsys E500 EPR spectrometer equipped with an Oxford Instruments 
ITC4 temperature controller and an ESR-900 helium flow crystat. Spectra were recorded at 12 K with 1 mW 
microwave power. A Bruker ER-4116DM cavity was used, with a resonant frequency of 9.63 GHz (in 
perpendicular mode), and 10 G (1 mT) field modulation at 100 kHz was employed. Computer simulations of EPR 
spectra were carried out using the matrix diagonalization program XSophe [Bruker Biospin GmbH (51)] assuming 
a spin Hamiltonian ℋ = βgBS + SDS, where S = 3/2 and D > 0 corresponds to an MS = |±1/2〉 ground state 
Kramers' doublet. For Co(II), generally |D| ≫ βgBS, and the spectrum is therefore insensitive to the precise 
value of D; in this work the arbitrary value D = 50 cm-1 was taken. The g tensor was assumed to have at least 
axial symmetry as this allows for a unique solution to the spin Hamiltonian in terms of the real g-
values, gz and gxy (or g∥ and g⊥), and the rhombic distortion of the axial zero-field splitting, E/D (52). The 
relationship between the resonance positions, geff(x,y,z), and these parameters is described in detail elsewhere 
(53, 54). Line widths were simulated using a single strain parameter for each of the principal orientations. Where 
simulations of spectra are shown that contain more than one species, spectra that could be well simulated 
assuming a single set of spin Hamiltonian parameters were used as basis spectra, and linear combinations of two 
(and no more than two) basis spectra were used to model the spectra collected after reaction times 
intermediate between those after which the basis spectra were recorded. Contributions of the individual species 
are estimated as ±5% of the total spins. 
Results 
Stopped-Flow Spectrophotometric Studies on Co(II)-Substituted L1.  
L1 has been reported to exhibit a steady-state kcat of 41 s-1 at 25 °C with nitrocefin as the substrate. Previous 
stopped-flow studies have shown that progress of the reaction of L1 with nitrocefin is sufficiently rapid that 
stopped-flow techniques at 25 °C may not access the entire catalytic cycle (44, 45, 50). Pre-steady-state kinetic 
studies were therefore conducted at both 2 and 25 °C. Although only a few data points could be collected for 
the initial phase of the reaction of L1 with nitrocefin at 25 °C, time-dependent spectrophotometry at 2 and 25 °C 
indicated that the course of the reaction at both temperatures was indistinguishable except for the 
proportionally lower rate constants for each step at the lower temperature. Studies at 2 °C on the reaction of 
100 μM Zn(II)-containing L1 with 100 μM nitrocefin revealed the time-dependent presence of three distinct 
species:  (1) at 7 ms after mixing, there was a small feature at 390 nm corresponding to substrate nitrocefin and 
a large feature at 665 nm that was previously assigned to a reaction intermediate (45), (2) at 36 ms after mixing, 
the feature at 665 nm was slightly less intense and exhibited a shoulder at 485 nm, and (3) at 1 s, the features at 
390 and 665 nm were absent, and a feature, which corresponds to product, at 485 nm was observed (Figure 2A). 
Single wavelength versus time plots (Figure 2B) of the features at 390, 485, and 665 nm were similar in 
appearance to those previously reported and were individually fitted to exponential equations as described in 
McMannus et al. (45). The decay of substrate (feature at 390 nm) was found to occur at a rate constant of 269 ± 
7 s-1, which was similar to the rate constant of intermediate (feature at 665 nm) formation (250 ± 5 s-1). The 
breakdown of the 665 nm intermediate occurred at a rate constant of 7.3 ± 0.1 s-1, which corresponded to the 
rate constant of product formation (feature at 485 nm) of 7.6 ± 0.1 s-1. These rate constants support the 
conclusion that the same mechanism that was predicted for L1 at 25 °C operates at 2 °C. 
 
Figure 2 (A) Rapid-scanning electronic absorption spectra of the reaction of 100 μM wild-type L1 with 100 μM 
nitrocefin at 2 °C. (B) Single wavelength versus time plots of the reaction of 100 μM wild-type L1 with 100 μM 
nitrocefin at 2 °C. The buffer used in both reactions was 50 mM HEPES, pH 7.0. 
 
Stopped-flow spectrophotometry at 2 and 25 °C indicated that the course of the reaction between Co(II)-
substituted L1 and nitrocefin was also indistinguishable at both temperatures, apart from the proportionally 
lower rate constants for each step at the lower temperature. Time-dependent absorption spectra recorded at 2 
°C of Co(II)-substituted L1 with nitrocefin as the substrate showed the same three species that were observed in 
the studies with Zn(II)-L1. However, at 36 ms, the intermediate at 665 nm converts to a fourth species that 
absorbs at 600 nm, and this second intermediate then is converted into product (Figure 3A). Single wavelength 
versus time plots of these data were individually fitted to exponential equations (Figure 3B). Substrate decay 
(390 nm) occurred at a rate constant of 67 ± 2 s-1, which is similar to the rate constant of formation of the 665 
nm intermediate (rate constant = 54 ± 3 s-1) and of the 600 nm intermediate (rate constant = 72 ± 2 s-1). The 
breakdown of both intermediates occurred at rate constants of 7.0 ± 0.1 s-1 (665 nm feature) and 6.7 ± 0.1 s-
1 (600 nm feature), which is similar to the rate constant of product formation of 8.8 ± 0.1 s-1. 
 
Figure 3 (A) Rapid-scanning electronic absorption spectra of the reaction of 100 μM Co(II)-substituted L1 with 
100 μM nitrocefin at 2 °C. (B) Single wavelength versus time plots of the reaction of 100 μM Co(II)-substituted L1 
with 100 μM nitrocefin at 2 °C. The buffer used in both reactions was 50 mM HEPES, pH 7.0. 
 
The possibility that the mechanism of Co(II)-L1 may be different from that of Zn(II)-L1 was considered. In 
particular, the possibility was explored that the appearance of a chromophoric intermediate with Co(II)-L1 was 
not observed with Zn(II)-L1, suggestive of a branched mechanism (55, 56). Such a mechanism would exhibit an 
initial burst phase in pre-steady-state kinetics, with a burst amplitude greater than the concentration of the 
enzyme (55, 56). However, no pre-steady-state burst could be detected in stopped-flow spectrophotometric 
experiments. Kinetic simulations of our data suggest a linear mechanism with multiple intermediates (Scheme 
1), one or more of which are as yet uncharacterized. This complex mechanism may be in operation with Zn(II)-L1 
as well as with Co(II)-L1. If, as we propose, the intermediates are metal-bound, then the electronic structure of 
the metal ion would influence the energies of the electronic absorption transitions observed for the 600 and 665 
nm intermediates with Co(II). It is entirely possible that although these transitions are just resolvable in Co(II)-L1, 
these transitions overlap sufficiently in Zn(II)-L1 that the absorption bands are not resolved. Temporal resolution 
of two spectrophotometrically indistinguishable intermediates is not possible in the studies with Zn-L1:  with 
Co(II)-L1, the kinetics of formation and decay of the 600 and 665 nm species are only slightly distinguishable. 
Thus, the simplest explanation of the data is that identical complex linear mechanisms operate for both Co(II)-L1 
and Zn(II)-L1. 
 
Scheme 1:  Kinetic Mechanism of L1 
 
The absorption spectrum of uncomplexed Co(II)-substituted-L1 reveals a broad feature at 550 nm with an 
extinction coefficient of 180 M-1 cm-1 that we previously assigned to overlapping Co(II) ligand field transitions 
(48). We examined whether there was a change in the intensities of these ligand field transitions during the 
reaction of Co(II)-L1 with nitrocefin; however, the presence of the more intense features at 600 and 485 nm 
effectively prevented the investigation of any spectral changes due to Co(II) ligand field transitions in the 550 nm 
region. 
Rapid-scanning spectrophotometric studies were also conducted in order to study the reaction of Co(II)-
substituted L1 with the other substrates, cephalothin, meropenem, and penicillin G. With these substrates, 
there were no observed features at 665 or 600 nm, which demonstrates that the chromophoric species 
observed during the reaction with nitrocefin are due to nitrocefin and its reaction products rather than a 
chromophoric center in the enzyme. In the absence of interference from absorption due to nitrocefin, Co(II) d-d 
bands could be observed with the other substrates. However, no significant changes in intensities of these 
transitions occurred during the reaction, suggesting that there is no change in the coordination number of the 
Co(II) ions during the time period in which these spectra were obtained (57). 
Rapid-Freeze-Quench EPR Spectra of Co(II)-Substituted L1.  
The EPR spectrum of Co(II)-substituted L1 is shown in Figure 4A and was simulated (Figure 4B) assuming a single 
(or two indistinguishable) paramagnetic species with S = 3/2, D ≫ βgBS, MS = |±1/2〉, gxy = 2.32, gz = 2.35, 
and E/D = 0.03. The origin of an apparently single component EPR signal, which we term the “resting” signal, 
from the dinuclear Co(II)-containing L1 is a matter for speculation, but the simulation was useful in modeling 
multicomponent spectra seen under reaction conditions. Variable temperature and power studies were carried 
out to try to identify other species, but no other Co(II) species were detected between 3.6 and 25 K and at 
powers up to 200 mW. [The simulation does contain an additional component that we assign to an Fe(III) species 
and is responsible for the multiple inflection points seen on the derivative feature of the Co(II) signals; this 
species, with resonances at g-values of 4.74, 3.99, and 3.66, was simulated as Fe(III) with S = 5/2, D ≫ βgBS, giso = 
1.97, and E/D = 0.244. This signal accounted for less than 0.2% of the total spins in the samples and was not 
investigated further.] Co(II)-substituted L1 was also examined by EPR after reaction with nitrocefin at 2 °C for 
various times. After 39 ms reaction time, the resting signal was replaced with another apparently single 
component spectrum (Figure 4E) that we term the “complex” signal. The complex signal was simulated (Figure 
4F) assuming S = 3/2, D ≫ βgBS, MS = |±1/2〉, gxy = 2.31, gz = 2.42, and E/D = 0.03. At the shortest reaction time 
that we could access, 10.4 ms, the spectrum (Figure 4C) could be well modeled (Figure 4D) as a mixture of 15% 
of the resting signal and 85% of the complex signal. When rapid-freeze-quenched samples were thawed and 
refrozen after 30 s, an EPR spectrum that consisted of roughly 50% of the resting signal and 50% of the complex 
signal was observed. This latter spectrum was very similar to the EPR spectrum (Figure 4I) exhibited upon the 
addition of the hydrolysis product of nitrocefin to Co(II)-substituted L1. 
 
Figure 4 Trace A shows the resting EPR signal of Co(II)-L1. Traces C, E, and G show the EPR spectra of Co(II)-L1 
upon reaction with nitrocefin for 10 ms at 2 °C (C), 39 ms at 2 °C (E), and 30 s at 23 °C (G). Trace I shows the EPR 
spectrum of Co(II)-L1 upon incubation for 5 min at 23 °C with the L1-hydrolyzed product of nitrocefin. Trace B is 
a computer simulation of (A) assuming S = 3/2, D ≫ βgBS (50 cm-1), MS = |±1/2〉, gxy = 2.32, gz = 2.35, and E/D = 
0.03. Trace F is a computer simulation of (E) assuming S = 3/2, D ≫ βgBS (50 cm-1), MS = |±1/2〉, gxy = 2.31, gz = 
2.42, and E/D = 0.03. Traces B and F also contain a 0.2% minor component due to Fe(III) with S = 5/2, D = 20 cm-
1, giso = 1.97, and E/D = 0.244. Traces D, H, and J are models for traces C, G, and I, respectively, and consist of 
(0.15 × B) + (0.85 × F) (D), (0.50 × B) + (0.50 × F) (H), and (0.52 × B) + (0.48 × F) (J). Experimental EPR spectra were 
recorded at 12 K with 1 mW microwave power at 9.63 GHz. 10 G (1 mT) field modulation at 100 kHz was 
employed. 
 
To compare with nitrocefin, analogous experiments were performed using the related cephalosporin 
cephalothin. After reaction times of 10 and 39 ms, the EPR signals obtained (Figure 5B,C) were indistinguishable 
from the complex signal that was seen with nitrocefin. However, after thawing a sample and refreezing after 60 
s, an entirely new signal was observed (Figure 4D). This signal could be readily simulated (Figure 5E), 
although gz was not resolved and all that can reliably be determined from the simulation is that gxy = 2.28 
and E/D is low (<0.05). A similar signal was observed (Figure 5F) upon addition of the hydrolysis product of 
cephalothin (containing no acetate group), though the signal contained a small amount of a second, poorly 
defined, broad component, estimated as accounting for 20% of the spin density by modeling using the complex 
signal. Two other substrates were examined by EPR of freeze-quenched samples, meropenem and penicillin G. 
With meropenem, signals were observed after 10 ms (Figure 6B) and 39 ms (Figure 6D) that were visually 
distinguishable from the complex signals exhibited upon reaction of Co(II)-substituted L1 with nitrocefin and 
with cephalothin, but simulation (Figure 6C) showed their EPR parameters to be very similar, with only a slight 
difference in E/D, 0.05 and 0.03 for meropenem and nitrocefin, respectively. After thawing a sample and 
refreezing after 60 s, the signal changed slightly (Figure 6E), but a new signal (Figure 6F) was seen upon addition 
of the hydrolysis product of meropenem to Co(II)-substituted L1. This signal could not be well simulated as 
either a single species or a mixture of any of the other EPR signals from Co(II)-substituted L1. Somewhat similar 
behavior was exhibited upon the reaction of Co(II)-substituted L1 with penicillin G. A signal (Figure 7B) was 
observed after 10 ms that superficially resembled the complex signal, though the simulation (Figure 7C) 
indicated slightly different parameters of gxy = 2.38, gz = 2.50, and E/D = 0.005. This signal persisted when the 
sample was thawed and refrozen after 30 s (Figure 7D), but, as with meropenem, a different signal was observed 
(Figure 7E) upon adding the hydrolysis product of penicillin G to Co(II)-substituted L1. An attempt to model the 
spectrum using a mixture of the complex and resting signals was not entirely successful (Figure 7F), and it is 
likely that new species are involved. 
 
Figure 5 Trace A shows the resting EPR signal of Co(II)-L1. Traces B, C, and D show the EPR spectra of Co(II)-L1 
upon reaction with cephalothin for 10 ms at 2 °C (B), 39 ms at 2 °C (C), and 60 s at 23 °C (D). Trace F shows the 
EPR spectrum of Co(II)-L1 upon incubation for 5 min at 23 °C with the L1-hy-drolyzed product of cephalothin. 
Trace E is a computer simulation of (D) assuming S = 3/2, D ≫ βgBS (50 cm-1), MS = |±1/2〉, gxy = 2.28, gz = 2.35, 
and E/D = 0.03. Trace G is a model for trace F and consists of (0.80 × B) + (0.20 × trace F of Figure 4). Trace G also 
contains a 0.2% minor component due to Fe(III) with S = 5/2, D = 20 cm-1, giso = 1.97, and E/D = 0.244. 
Experimental EPR spectra were recorded at 12 K with 1 mW microwave power at 9.63 GHz. 10 G (1 mT) field 
modulation at 100 kHz was employed. 
 
 
Figure 6 Trace A shows the resting EPR signal of Co(II)-L1. Traces B, D, and E show the EPR spectra of Co(II)-L1 
upon reaction with meropenem for 10 ms at 2 °C (B), 39 ms at 2 °C (D), and 60 s at 23 °C (E). Trace F shows the 
EPR spectrum of Co(II)-L1 upon incubation for 5 min at 23 °C with the L1-hydrolyzed product of meropenem. 
Trace C is a computer simulation of (B) assuming S = 3/2, D ≫ βgBS (50 cm-1), MS = |±1/2〉, gxy = 2.32, gz = 2.35, 
and E/D = 0.05. Experimental EPR spectra were recorded at 12 K with 1 mW microwave power at 9.63 GHz. 10 G 
(1 mT) field modulation at 100 kHz was employed. 
 
 
Figure 7 Trace A shows the resting EPR signal of Co(II)-L1. Traces B, D, and E show the EPR spectra of Co(II)-L1 
upon reaction with penicillin G for 10 ms at 2 °C (B), 39 ms at 2 °C (D), and 60 s at 23 °C (E). Trace F shows the 
EPR spectrum of Co(II)-L1 upon incubation for 5 min at 23 °C with the L1-hydrolyzed product of penicillin G. 
Trace C is a computer simulation of (B) assuming S = 3/2, D ≫ βgBS (50 cm-1), MS = |±1/2〉, gxy = 2.38, gz = 2.50, 
and E/D = 0.005. Trace F is a model for trace E and consists of (0.40 × C) + (0.60 × trace B of Figure 4). Trace F 
also contains a 0.2% minor component due to Fe(III) with S = 5/2, D = 20 cm-1, giso = 1.97, and E/D = 0.244. 
Experimental EPR spectra were recorded at 12 K with 1 mW microwave power at 9.63 GHz. 10 G (1 mT) field 
modulation at 100 kHz was employed. 
 
Discussion 
Kinetic studies on L1 (44, 45) and the related enzymes metallo-β-lactamase CcrA from B. fragilis (43, 46) and β-
lactamase II (58) have suggested a common mechanism for the hydrolysis of the chromophoric substrate 
nitrocefin by these enzymes. The proposed mechanism invokes rapid formation of an intermediate complex, 
which may involve one or more steps, followed by rate-limiting breakdown of this penultimate species to 
complete the reaction cycle. Stopped-flow fluorescence studies suggest that the hydrolyses of other substrates 
of L1, including carbapenems and other cephalosporins, proceed through analogous mechanisms, though the 
chemical natures of the intermediates may differ in an important respect (44). With nitrocefin, it has 
been proposed that the intermediate whose breakdown is rate-limiting is a ring-opened, anionic species and 
that this species is stabilized by both interaction with the catalytic site metal ions in L1 and by the presence of a 
dinitro-substituted styryl substituent that can accommodate excess electron density through the formation of 
resonance structures (43, 46). However, the available evidence suggests that the β-lactam bond remains intact 
as the stable intermediate forms when using other β-lactams as substrates (44). The breakdown of these 
intermediates with other substrates must involve hydrolytic cleavage of the β-lactam amide bond, and thus, the 
mechanism of hydrolysis of nitrocefin may be unique. In the absence of the need for stabilization of a high-
energy intermediate, such as the proposed nitrogen anionic species of nitrocefin, it is not immediately clear 
whether the metal ions would be expected to perform a role in formation of an enzyme−substrate complex. 
Prior to the present study, no direct evidence for such a role had been presented. 
Comparison of the RFQ-EPR and stopped-flow spectrophotometric data for the reaction of Co(II)-substituted L1 
with nitrocefin confirmed the earlier proposals that the metal ions are indeed involved in stabilizing the rate-
limiting complex. The rate constant of formation of the well-studied 665 nm complex was measured at 54 s-1 at 
2 °C and that of the appearance of absorbance at 600 nm, not observed with the native Zn(II) enzyme, at 72 s-1. 
Since the feature at 600 nm occurred only in the time-dependent spectrophotometric studies on Co(II)-
substituted L1, and not Zn(II)-containing L1, this feature is obligatorily dependent upon the chemical nature of 
Co(II); i.e., it must involve the electronic structure of the metal ion. Thus, we can only assign this feature to a 
Co(II)-bound intermediate species. That we do not see the two distinct intermediates with Zn(II) may be due 
simply to poorer spectral resolution due to slight differences in the electronic structures of the intermediates, 
entirely consistent with the intimate involvement of the metal ions in the intermediates. In the case of more 
extensive spectral overlap in the Zn(II) intermediate, temporal resolution would not be possible because of the 
similar rate constants of formation (54 versus 72 s-1) and essentially indistinguishable rate constants of decay 
(7.0 versus 6.7 s-1) of the two intermediates. 
The stopped-flow spectrophotometric data indicate that within the shortest reaction time accessible in the RFQ-
EPR experiment, 10 ms, significant formation of the enzyme−substrate complex would have occurred. Should 
the metal ions be involved in the formation of this complex, the consequent perturbation of the electronic 
structure would be observable in the EPR spectrum. This was, indeed, the case; the EPR data showed that only 
15% of the enzyme remained in the resting state after 10 ms and that after 39 ms the resting state, which 
decayed at a rate constant of 67 s-1 in the stopped-flow experiments, was undetectable and only the complex 
signal remained. 
Earlier work (43−46) had suggested that the formation of the intermediate with nitrocefin likely involves the 
metal ions. However, this mechanism may be unique for nitrocefin. There is as yet no clear rationale for the role 
of metal ions in the formation or stabilization of the intermediate in the proposed closed-ring-intermediate 
mechanism proposed for the therapeutic antibiotic substrates of L1 (44). RFQ-EPR studies were therefore 
carried out with cephalothin, a nonchromophoric cephalosporin related to nitrocefin but lacking the dinitrostyryl 
substituent, and, therefore, more strictly analogous to cefaclor, a cephalosporin substrate that has been 
proposed to form a closed-ring intermediate when reacted with L1 (44). After the shortest available reaction 
time, 10 ms, the resting enzyme signal was completely undetectable, and a signal indistinguishable from the 
complex signal of Co(II)-L1-nitrocefin was observed. This signal persisted after a 39 ms reaction time. Thus, it is 
clear that with cephalothin, as with nitrocefin, a perturbation of the electronic structures of one or both of the 
metal ions occurs in a time consistent with formation of the intermediate. Clearly, then, cephalosporins that are 
proposed to form both open-ring and closed-ring intermediates interact with the metal center of L1 in doing so. 
To further test the generality of the involvement of the metal center of L1 in formation of reaction 
intermediates, meropenem, a carbapenem, and penicillin G were also examined. Although the literature values 
of kcat for both meropenem and nitrocefin are reported to vary somewhat depending on precise conditions 
(18, 44, 59), they appear to be generally comparable, whereas the kcat for penicillin G is significantly higher 
(34, 49, 50). As with the cephalosporins, both of these substrates cease to exhibit the resting signal after only 
very short reaction times, indicative of participation of the metal center in formation of the intermediate. 
In addition to providing kinetic information, some structural information can often be derived from EPR 
of S = 3/2 Co(II) (52). The axial zero-field splitting, D, is generally sufficiently large that only one of the two 
Kramers' doublets is thermally populated. Signals from the MS = |±3/2〉 doublet are effectively diagnostic for 
tetrahedral-based geometry, whereas signals from the MS = |±1/2〉 doublet indicate five- or six-coordinate 
Co(II). The rhombic distortion of the axial zero-field splitting, E/D, where 1/3 ≥ E/D ≥ 0, is a measure of the 
amount of axial electronic symmetry and thus reflects the symmetry of the ligand field. Further information can 
be extracted from line width measurements. Co(II) often exhibits broad lines due to extensive strain in g, in A, 
and in the zero-field splitting tensor, D. These strains are, in turn, due to the freezing out of a continuity of 
microheterogeneous confomers, afforded by vibrational flexibility and often associated with solvent-derived 
ligands, such as water or hydroxyl, with poorly defined orientations. On the other hand, the observation of 
resolved hyperfine structure and very narrow lines indicates a very tightly constrained ligand sphere such as 
would be provided by polydentate ligands, including rigid proteins. 
All of the signals that were observed from Co(II)-L1 were due to transitions in the MS = |±1/2〉 Kramers' doublet 
and are due, therefore, to either five- or six-coordinate Co(II). The signals are all essentially axial, with E/D ≤ 
0.05, and this high degree of axial electronic symmetry is suggestive of an axially symmetric ligand field. The g-
values for the resting and complex signals are close to those computed for an axially symmetric tetragonal 
system, where gz = 2.43 and gxy = 2.50 (60), and support the conclusion that the EPR-detected Co(II) is in an 
axially symmetric ligand field. The line shapes of the various spectra are more clearly distinct, reflecting different 
orientational distributions and magnitudes of the strain terms that determine them. The spectra of high-spin 
Co(II) are dominated by the zero-field splittings, and the line widths are dominated by multiple strain terms 
in D (which includes E), A, and g. Simulation of the spectra is often useful because it provides a value for E/D, a 
measure of the degree of the electronic axial symmetry. However, there is no unique solution to the spin 
Hamiltonian unless an axial or isotropic g tensor is assumed. Consequently, the kind of detailed information that 
is available for S = 1/2 systems from small anisotropies in g is elusive at present for high-spin Co(II) (note that we 
quote g-values to two decimal places, whereas g-values can be reliably determined to four decimal places 
in S = 1/2 systems). The often high degree of strain renders superhyperfine structure unresolvable. Thus, high-
resolution structural information is often not forthcoming from the EPR of Co(II). However, even subtle changes 
in the line shape are indicative of substantial changes in the Co(II) coordination environment; indeed, due to the 
broad lines and relative insensitivity to g of the spectra, substantial changes are required in the Co(II) electronic 
structure if any change in the EPR spectrum is to be observed. Therefore, while detailed structural information 
from the EPR spectra is not available, the essential point remains that the changes in the EPR spectra upon 
reaction with substrates, particularly changes in the large strain parameters, are indicative of major changes in 
the Co(II) environment. 
One structural detail that must be considered as a catalytic intermediate is that of a dinuclear metal center that 
incorporates a substrate moiety in the form of a μ-bridging ligand. In cases where substrates or inhibitors form 
μ-bridges, the EPR signal is typically lost in antiferromagnetically coupled dicobalt species, or else an integer spin 
signal may be observed (61−63). In the spectra of analogous heterodinuclear Co−Zn systems, very narrow lines 
are observed with resolved 59Co hyperfine structure (52, 61, 62). The exhibition of S = 3/2 signals with large line 
widths in all of the spectra of Co(II)-L1 argues strongly against any of the species containing a substrate-derived 
μ-bridge bound to both metal ions. 
Further information on the catalytic cycle of L1 can be obtained by investigation of the interaction of the 
hydrolysis products of substrates with the enzyme. With each of the four substrates examined, an EPR signal 
was obtained upon the addition of product to Co(II)-L1 that was different from both the resting signal and the 
complex signals obtained at reaction times optimal for generating the intermediate. In the case of nitrocefin and 
penicillin G, the signals obtained upon adding product to Co(II)-L1 were similar to models generated by adding 
proportions of the complex and resting signals, though the model was not a particularly good fit to the data for 
penicillin G. It is unclear, then, whether any new species are involved or whether the product-bound form of the 
enzyme is very similar to the intermediate but with a poor binding constant. It is interesting that the spectrum 
from Co(II)-L1 incubated with penicillin G for 60 s, after which all of the penicillin G would be expected to have 
been hydrolyzed, gave a spectrum different from that of Co(II)-L1 to which the preprepared hydrolysis product 
was added. It is possible that, at the very high concentration of reagents being used, substrate inhibition may 
occur due to transient formation of nonhydrolyzable intermediates. Alternatively, product dissociation and 
association may be very slow. Although the precise mechanism for the formation of product-related EPR signals 
is unknown, however, it is clear that there is an interaction of the hydrolysis products of penicillin G and 
nitrocefin with Co(II)-L1. An EPR signal, which could not be modeled by assuming mixtures of resting and 
complex signals, was seen upon adding the hydrolysis product of meropenem to Co(II)-L1, though features in the 
spectra suggest that there is at least some contribution from the resting signal. The effect of adding the 
hydrolysis product of cephalothin to Co(II)-L1, however, was striking. A new species was observed with atypically 
narrow gxy features but with gz so broadened as to be unresolvable. The signal was also seen when cephalothin 
was allowed to react completely with Co(II)-L1. In the case of cephalothin, then, clear evidence exists for a 
distinct product complex that is formed in essentially stoichiometric amounts. 
The EPR data clearly indicate that the products of hydrolysis interact with the catalytic metal ions of Co(II)-L1 to 
form significant amounts of an enzyme−product complex. Importantly, previous kinetic simulations on L1 
assumed reversible binding of products to the resting enzyme (45); the EPR data presented herein support this 
assumption and emphasize that this step must be included in future kinetic simulations on L1. 
Through RFQ-EPR, it has been possible to characterize EPR-detectable Co(II) in Co(II)-L1. Co(II)-L1 contains two 
Co(II) ions per monomer, presumably in close proximity in a dinuclear active site. However, the EPR spectrum 
from the resting enzyme can be explained in terms of a single paramagnetic species. Upon reaction with 
cephalothin for 10−40 ms, the resting signal is converted into the complex signal, which can also be explained in 
terms of a single paramagnetic species. Finally, upon complete hydrolysis of cephalothin, yet another single 
species is exhibited in the EPR, corresponding to an enzyme−product complex. In principle, to determine the 
number of Co(II) ions contributing to the EPR signal, the EPR spectrum can be doubly integrated and the spin 
concentration calculated. In practice, this can be extremely difficult for high-spin Co(II), particularly for dinuclear 
systems. The spectral envelope can be extremely wide, 500 mT (5000 G) or more, and even small errors in 
background subtraction can affect the quantitation significantly. The spectra are also weak in intensity, due to 
the broad lines and the dilution of the enzyme by a factor of 4 as a consequence of the RFQ procedure, and so 
contain much noise. Because the spectra are weak, it is often impractical to record spectra under strictly 
nonsaturating or nonpassage conditions, and integration results are therefore not valid. Finally, in a dinuclear 
system there is always the possibility, as occurs in VpAP (53), that a proportion of the molecules contain a 
strongly spin-exchange coupled pair of Co(II) ions that exhibit no EPR signal. Quantitation of the signals from 
Co(II)-L1, therefore, is impracticable. However, some insight into the contributions of the two Co(II) ions to the 
EPR signal may be available from consideration of the crystal structure of L1 (35) and the EPR data. The two Zn 
ions in L1 are each ligated by three amino acid side chains and are bridged by a solvent-derived oxygen atom 
(presumably −OH or H2O). In the case of Zn1, the amino acids are all histidines, furnishing a four-coordinate site, 
whereas Zn2 has two histidines, one aspartate ligand, and a terminal −OH or H2O. Zn2, then, has the possibility of 
being five-coordinate or even six-coordinate. All of the EPR signals observed from Co(II)-L1 can be assigned to 
either five- or six-coordinate Co(II). Four-coordinate distorted tetrahedral Co(II) gives rise to EPR signals in 
the MS = |±3/2〉 doublet. However, as the distortion is decreased, E/D → 0, gxy → 0, and the transition 
probability, i.e., the signal intensity, tends to zero. Therefore, for axially symmetric tetrahedral Co(II), the signal 
is either very weak indeed or nonexistent. Also, MS = |±3/2〉 species of Co(II) are often very fast relaxers; in the 
case of VpAP in complexation with thiol-based inhibitors, microwave powers of up to 550 mW at 3.6 K were 
required to observe MS = |±3/2〉 EPR signals (64, 65). It is, then, entirely possible that a tetrahedral site in Co(II)-
L1 could go undetected. The electronic absorption spectrum of Co(II)-substituted L1 does indeed indicate the 
presence of a tetrahedral Co(II) ion; the extinction coefficient of 180 M-1 cm-1 is too high to be due to two five- or 
six-coordinate Co(II) ions and, instead, is consistent with a four- and a five- or six-coordinate Co(II) ion (66). That 
we do see clear substrate and product binding to a five- or six-coordinate EPR-detected Co(II) in Co(II)-L1 leads 
us to propose that Zn2 must play an intimate role in hydrolysis. The role of Zn1 is as yet unclear, though we as yet 
have no evidence from either EPR or optical spectroscopy for the substrate-induced conversion of a tetrahedral 
Co(II) to a five- or six-coordinate Co(II) ion during catalysis. The available crystallographic, EPR, and electronic 
absorption data, then, indicate no clear role for Zn1, and further investigation of Zn1 is clearly warranted. 
The use of stopped-flow spectrophotometry and RFQ-EPR has shown that the formation of the intermediate in 
the reaction of L1 with three classes of β-lactam-containing antibiotics involves binding at one or both of the 
active site metal ions. This binding occurs at a catalytically competent rate and produces spectroscopically 
distinct intermediates with different classes of substrate. However, the intermediates generated by nitrocefin 
and the other substrates are electronically similar, nonetheless, and the intimate involvement of the metal ions 
in formation and stabilization of the intermediate is general and, therefore, relevant to therapeutically 
important substrates. A previously unidentified interaction between the reaction products and the metal site of 
L1 has been characterized, and any full description of the kinetics and mechanism of the reaction must take into 
account product binding and dissociation. Consideration of the EPR and electronic absorption data, along with 
crystallographic information (35), leads us to propose that Zn2 is intimately involved in the hydrolytic reaction of 
L1. 
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